Speaker :

Dr. Vivek Agarwala, Medical Oncologist, Kolkata

Assessing tumour fraction of CSF cfDNA improves diagnostic accuracy and therapeutic monitoring in breast cancer leptomeningeal metastasis (BCLM)

Author: Amanda Fitzpatrick

Citation: Annals of Oncology (2020) 31 (suppl_4): S274-S302

SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in ER+/ HER2- metastatic breast cancer (mBC): Biomarker analyses from a phase I/II study

Author: Sarat Chandarlapaty 

Citation: Annals of Oncology (2020) 31 (suppl_4): S348-S395

Pooled ctDNA analysis of the MONALEESA (ML) phase III advanced breast cancer (ABC) trials

Author: Fabrice Andre 

Citation: Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020) 1009-1009